ABSTRACT
BACKGROUND: Anticoagulants including direct oral anticoagulants (DOACs) are among the highest-risk medications in the United States. We postulated that routine consultation and follow-up from a clinical pharmacist would reduce clinically important medication errors (CIMEs) among patients beginning or resuming a DOAC in the ambulatory care setting. OBJECTIVE: To evaluate the effectiveness of a multicomponent intervention for reducing CIMEs. DESIGN: Randomized controlled trial. PARTICIPANTS: Ambulatory patients initiating a DOAC or resuming one after a complication. INTERVENTION: Pharmacist evaluation and monitoring based on the implementation of a recently published checklist. Key elements included evaluation of the appropriateness of DOAC, need for DOAC affordability assistance, three pharmacist-initiated telephone consultations, access to a DOAC hotline, documented hand-off to the patient's continuity provider, and monitoring of follow-up laboratory tests. CONTROL: Coupons and assistance to increase the affordability of DOACs. MAIN MEASURE: Anticoagulant-related CIMEs (Anticoagulant-CIMEs) and non-anticoagulant-related CIMEs over 90 days from DOAC initiation; CIMEs identified through masked assessment process including two physician adjudication of events presented by a pharmacist distinct from intervention pharmacist who reviewed participant electronic medical records and interview data. ANALYSIS: Incidence and incidence rate ratio (IRR) of CIMEs (intervention vs. control) using multivariable Poisson regression modeling. KEY RESULTS: A total of 561 patients (281 intervention and 280 control patients) contributed 479 anticoagulant-CIMEs including 31 preventable and ameliorable ADEs and 448 significant anticoagulant medication errors without subsequent documented ADEs (0.95 per 100 person-days). Failure to perform required blood tests and concurrent, inappropriate usage of a DOAC with aspirin or NSAIDs were the most common anticoagulant-related CIMEs despite pharmacist documentation systematically identifying these issues when present. There was no reduction in anticoagulant-related CIMEs among intervention patients (IRR 1.17; 95% CI 0.98-1.42) or non-anticoagulant-related CIMEs (IRR 1.05; 95% CI 0.80-1.37). CONCLUSION: A multi-component intervention in which clinical pharmacists implemented an evidence-based DOAC Checklist did not reduce CIMEs. NIH TRIAL NUMBER: NCT04068727.
Subject(s)
Anticoagulants , Pharmacists , Humans , Anticoagulants/adverse effects , Medication Errors , Ambulatory Care , Electronic Health Records , Administration, OralABSTRACT
The current article describes an intervention aimed at emergency department (ED) nurses and physicians that was designed to address the challenges of managing delirium in the ED environment. The intervention development process followed the Medical Research Council principles paired with a user-centered design perspective. Expert clinicians and nursing staff were involved in the development process. As a result, the SCREENED-ED intervention includes four major components: screening for delirium, informing providers, an acronym (ALTERED), and documentation in the electronic health record. The acronym "ALTERED" includes seven key elements of delirium management that were considered the most evidence-based, relevant, and practical for the ED. Nurses are at the frontline of delirium recognition and management and the SCREENED-ED intervention with the ALTERED acronym holds the potential to improve nursing care in this complex clinical setting. [Journal of Gerontological Nursing, 47(12), 13-17.].
Subject(s)
Delirium , Emergency Medical Services , Delirium/diagnosis , Delirium/therapy , Delivery of Health Care , Emergency Service, Hospital , Humans , Mass ScreeningABSTRACT
BACKGROUND: Long-term trends in the incidence rates (IRs) and hospital case-fatality rates (CFRs) of ventricular tachycardia (VT) and ventricular fibrillation (VF) among patients hospitalized with acute myocardial infarction (AMI) have not been recently examined. METHODS: We used data from 11,825 patients hospitalized with AMI at all 11 medical centers in central Massachusetts on a biennial basis between 1986 and 2011. Multivariable adjusted logistic regression modeling was used to examine trends in hospital IRs and CFRs of VT and VF complicating AMI. RESULTS: The median age of the study population was 71 years, 57.9% were men, and 94.7% were white. The hospital IRs declined from 14.3% in 1986/1988 to 10.5% in 2009/2011 for VT and from 8.2% to 1.7% for VF. The in-hospital CFRs declined from 27.7% to 6.9% for VT and from 49.6% to 36.0% for VF between 1986/1988 and 2009/2011, respectively. The IRs of both early (<48 hours) and late VT and VF declined over time, with greater declines in those of late VT and VF. The incidence rates of VT declined similarly for patients with either an ST-segment elevation myocardial infarction (STEMI) or non-STEMI, whereas they only declined in those with VF and a STEMI. CONCLUSIONS: The hospital IRs and CHRs of VT and VF complicating AMI have declined over time, likely because of changes in acute monitoring and treatment practices. Despite these encouraging trends, efforts remain needed to identify patients at risk for these serious ventricular arrhythmias so that preventive and treatment strategies might be implemented as necessary.
Subject(s)
Hospital Mortality/trends , Myocardial Infarction/complications , Tachycardia, Ventricular/epidemiology , Ventricular Fibrillation/epidemiology , Aged , Aged, 80 and over , Female , Humans , Incidence , Logistic Models , Male , Massachusetts/epidemiology , Middle Aged , Myocardial Infarction/epidemiology , Non-ST Elevated Myocardial Infarction/complications , Non-ST Elevated Myocardial Infarction/epidemiology , ST Elevation Myocardial Infarction/complications , ST Elevation Myocardial Infarction/epidemiology , Tachycardia, Ventricular/complications , Tachycardia, Ventricular/mortality , Time Factors , Ventricular Fibrillation/complications , Ventricular Fibrillation/mortalityABSTRACT
Mechanical circulatory support is now widely accepted as a viable long-term treatment option for patients with end-stage heart failure (HF). As the range of indications for the implantation of ventricular assist devices grows, so does the number of patients living in the community with durable support. Because of their underlying disease and comorbidities, in addition to the presence of mechanical support, these patients are at a high risk for medical urgencies and emergencies (Table 1). Thus, it is the responsibility of clinicians to understand the basics of their emergency care. This consensus document represents a collaborative effort by the Heart Failure Society of America, the Society for Academic Emergency Medicine, and the International Society for Heart and Lung Transplantation (ISHLT) to educate practicing clinicians about the emergency management of patients with ventricular assist devices. The target audience includes HF specialists and emergency medicine physicians, as well as general cardiologists and community-based providers.
Subject(s)
Emergencies/epidemiology , Emergency Medical Services , Heart Failure , Postoperative Complications , Prosthesis Implantation , American Heart Association , Consensus , Disease Progression , Emergency Medical Services/methods , Emergency Medical Services/standards , Heart Failure/complications , Heart Failure/mortality , Heart Failure/surgery , Heart Transplantation/methods , Heart Transplantation/statistics & numerical data , Heart-Assist Devices/adverse effects , Heart-Assist Devices/classification , Humans , International Cooperation , Postoperative Complications/classification , Postoperative Complications/etiology , Postoperative Complications/therapy , Prosthesis Implantation/adverse effects , Prosthesis Implantation/instrumentation , Prosthesis Implantation/methods , United States , Waiting ListsABSTRACT
BACKGROUND: Little is known about the association of hyperglycemia with the development of ventricular tachycardia (VT) in patients hospitalized with acute myocardial infarction (AMI) which we examined in the present study. The objectives of this community-wide observational study were to examine the relation between elevated serum glucose levels at the time of hospital admission for AMI and occurrence of VT, and time of occurrence of VT, during the patient's acute hospitalization. METHODS: We used data from a population-based study of patients hospitalized with AMI at all central Massachusetts medical centers between 2001 and 2011. Hyperglycemia was defined as a serum glucose level ≥ 140 mg/dl at the time of hospital admission. The development of VT was identified from physicians notes and electrocardiographic findings by our trained team of data abstractors. RESULTS: The average age of the study population was 70 years, 58.0% were men, and 92.7% were non-Hispanic whites. The mean and median serum glucose levels at the time of hospital admission were 171.4 mg/dl and 143.0, respectively. Hyperglycemia was present in 51.9% of patients at the time of hospital admission; VT occurred in 652 patients (15.8%), and two-thirds of these episodes occurred during the first 48 h after hospital admission (early VT). After multivariable adjustment, patients with hyperglycemia were at increased risk for developing VT (adjusted OR = 1.48, 95% CI = 1.23-1.78). The presence of hyperglycemia was significantly associated with early (multivariable adjusted OR = 1.39, 95% CI = 1.11-1.73) but not with late VT. Similar associations were observed in patients with and without diabetes and in patients with and without ST-segment elevation AMI. CONCLUSIONS: Efforts should be made to closely monitor and treat patients who develop hyperglycemia, especially early after hospital admission, to reduce their risk of VT.
Subject(s)
Hyperglycemia/epidemiology , Non-ST Elevated Myocardial Infarction/epidemiology , Patient Admission , ST Elevation Myocardial Infarction/epidemiology , Tachycardia, Ventricular/epidemiology , Aged , Aged, 80 and over , Biomarkers/blood , Blood Glucose/metabolism , Female , Humans , Hyperglycemia/blood , Hyperglycemia/diagnosis , Hyperglycemia/therapy , Incidence , Male , Massachusetts/epidemiology , Middle Aged , Non-ST Elevated Myocardial Infarction/diagnosis , Non-ST Elevated Myocardial Infarction/therapy , Prognosis , Risk Assessment , Risk Factors , ST Elevation Myocardial Infarction/diagnosis , ST Elevation Myocardial Infarction/therapy , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/therapy , Time FactorsABSTRACT
BACKGROUND: Atrial fibrillation (AF) is a common and dangerous rhythm abnormality. Smartphones are increasingly used for mobile health applications by older patients at risk for AF and may be useful for AF screening. OBJECTIVES: To test whether an enhanced smartphone app for AF detection can discriminate between sinus rhythm (SR), AF, premature atrial contractions (PACs), and premature ventricular contractions (PVCs). METHODS: We analyzed two hundred and nineteen 2-minute pulse recordings from 121 participants with AF (n = 98), PACs (n = 15), or PVCs (n = 15) using an iPhone 4S. We obtained pulsatile time series recordings in 91 participants after successful cardioversion to sinus rhythm from preexisting AF. The PULSE-SMART app conducted pulse analysis using 3 methods (Root Mean Square of Successive RR Differences; Shannon Entropy; Poincare plot). We examined the sensitivity, specificity, and predictive accuracy of the app for AF, PAC, and PVC discrimination from sinus rhythm using the 12-lead EKG or 3-lead telemetry as the gold standard. We also administered a brief usability questionnaire to a subgroup (n = 65) of app users. RESULTS: The smartphone-based app demonstrated excellent sensitivity (0.970), specificity (0.935), and accuracy (0.951) for real-time identification of an irregular pulse during AF. The app also showed good accuracy for PAC (0.955) and PVC discrimination (0.960). The vast majority of surveyed app users (83%) reported that it was "useful" and "not complex" to use. CONCLUSION: A smartphone app can accurately discriminate pulse recordings during AF from sinus rhythm, PACs, and PVCs.
Subject(s)
Atrial Fibrillation/diagnosis , Atrial Premature Complexes/diagnosis , Heart Rate , Mobile Applications , Photoplethysmography/instrumentation , Pulse , Smartphone , Telemetry/instrumentation , Ventricular Premature Complexes/diagnosis , Aged , Algorithms , Atrial Fibrillation/physiopathology , Atrial Premature Complexes/physiopathology , Attitude to Computers , Diagnosis, Differential , Electrocardiography , Female , Humans , Male , Middle Aged , Patient Satisfaction , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Signal Processing, Computer-Assisted , Surveys and Questionnaires , Ventricular Premature Complexes/physiopathologyABSTRACT
BACKGROUND: Patient safety incident (PSI) discovery is an essential component of quality improvement. When submitted, incident reports may provide valuable opportunities for PSI discovery. However, little objective information is available to date to quantify or demonstrate this value. The objective of this investigation was to assess how often Emergency Department (ED) incident reports submitted by different sources led to the discovery of PSIs. METHODS: A standardized peer review process was implemented to evaluate all incident reports submitted to the ED. Findings of the peer review analysis were recorded prospectively in a quality improvement database. A retrospective analysis of the quality improvement database was performed to calculate the PSI capture rates for incident reports submitted by different source groups. RESULTS: 363 incident reports were analyzed over a period of 18 months; 211 were submitted by healthcare providers (HCPs) and 126 by non-HCPs. PSIs were identified in 108 resulting in an overall capture rate of 31%. HCP-generated reports resulted in a 44% capture rate compared to 10% for non-HCPs (p < 0.001). There was no difference in PSI capture between sub-groups of HCPs and non-HCPs. CONCLUSION: HCP-generated ED incident reports were much more likely to capture PSIs than reports submitted by non-HCPs. However, HCP reports still led to PSI discovery less than half the time. Further research is warranted to develop effective strategies to improve the utility of incident reports from both HCPs and non-HCPs.
Subject(s)
Emergency Service, Hospital/standards , Medical Errors/statistics & numerical data , Patient Safety/statistics & numerical data , Quality Assurance, Health Care/methods , Quality Improvement , Databases, Factual , Emergency Service, Hospital/statistics & numerical data , Humans , Retrospective StudiesABSTRACT
BACKGROUND: Cognitive impairment is highly prevalent in patients with heart failure and is associated with adverse outcomes. However, whether specific cognitive abilities (eg, memory vs executive function) are impaired in heart failure has not been fully examined. We investigated the prevalence of impairment in 3 cognitive domains in patients hospitalized with acute decompensated heart failure (ADHF) and the associations of impairment with demographic and clinical characteristics. METHODS: The sample included 744 patients hospitalized with ADHF (mean age 72 years, 46% female) at 5 medical centers. Impairment was assessed in 3 cognitive domains (memory, processing speed, executive function) using standardized measures. Demographic and clinical characteristics were obtained from a structured interview and medical record review. RESULTS: A total of 593 (80%) of 744 patients were impaired in at least 1 cognitive domain; 32%, 31%, and 17% of patients were impaired in 1, 2, or all 3 cognitive domains, respectively. Patients impaired in more than 1 cognitive domain were significantly older, had less formal education, and had more noncardiac comorbidities (all P values < .05). In multivariable adjusted analyses, patients with older age and lower education had higher odds of impairment in 2 or more cognitive domains. Depressed patients had twice the odds of being impaired in all 3 cognitive domains (odds ratio 1.98, 95% CI 1.08-3.64). CONCLUSION: Impairments in executive function, processing speed, and memory are common among patients hospitalized for ADHF. Recognition of these prevalent cognitive deficits is critical for the clinical management of these high-risk patients.
Subject(s)
Cognition Disorders , Executive Function , Heart Failure , Hospitalization/statistics & numerical data , Memory Disorders , Psychomotor Performance , Acute Disease , Aged , Canada/epidemiology , Cognition Disorders/diagnosis , Cognition Disorders/epidemiology , Cognition Disorders/etiology , Cognition Disorders/physiopathology , Demography , Female , Geriatric Assessment/methods , Heart Failure/complications , Heart Failure/epidemiology , Heart Failure/physiopathology , Heart Failure/psychology , Heart Failure/therapy , Humans , Interview, Psychological , Male , Medical Records, Problem-Oriented , Memory Disorders/diagnosis , Memory Disorders/etiology , Memory Disorders/physiopathology , Neuropsychological Tests , Prevalence , Risk FactorsABSTRACT
BACKGROUND: Emergency Department (ED) care has been reported to be prone to patient safety incidents (PSIs). Improving our understanding of PSIs is essential to prevent them. A standardized, peer review process was implemented to identify and analyze ED PSIs. The primary objective of this investigation was to characterize ED PSIs identified by the peer review process. A secondary objective was to characterize PSIs that led to patient harm. In addition, we sought to provide a detailed description of the peer review process for others to consider as they conduct their own quality improvement initiatives. METHODS: An observational study was conducted in a large, urban, tertiary-care ED. Over a two-year period, all ED incident reports were investigated via a standardized, peer review process. PSIs were identified and analyzed for contributing factors including systems failures and practitioner-based errors. The classification system for factors contributing to PSIs was developed based on systems previously reported in the emergency medicine literature as well as the investigators' experience in quality improvement and peer review. All cases in which a PSI was discovered were further adjudicated to determine if patient harm resulted. RESULTS: In 24 months, 469 cases were investigated, identifying 152 PSIs. In total, 188 systems failures and 96 practitioner-based errors were found to have contributed to the PSIs. In twelve cases, patient harm was determined to have resulted from PSIs. Systems failures were identified in eleven of the twelve cases in which a PSI resulted in patient harm. CONCLUSION: Systems failures were almost twice as likely as practitioner-based errors to contribute to PSIs, and systems failures were present in the majority of cases resulting in patient harm. To effectively reduce PSIs, ED quality improvement initiatives should focus on systems failure reduction.
Subject(s)
Emergency Service, Hospital/statistics & numerical data , Medical Errors/statistics & numerical data , Patient Safety/statistics & numerical data , Peer Review, Health Care/standards , Quality Assurance, Health Care/standards , Adult , Aged , Aged, 80 and over , Emergency Service, Hospital/standards , Female , Humans , Male , Massachusetts , Middle Aged , Patient Safety/standards , Peer Review, Health Care/methods , Prospective Studies , Quality Assurance, Health Care/methods , Quality Improvement , Quality Indicators, Health Care/statistics & numerical dataABSTRACT
INTRODUCTION: Lactate measurement has been used to identify critical medical illness and initiate early treatment strategies. The prehospital environment offers an opportunity for very early identification of critical illness and commencement of care. HYPOTHESIS: The investigators hypothesized that point-of-care lactate measurement in the prehospital aeromedical environment would: (1) identify medical patients with high mortality; (2) influence fluid, transfusion, and intubation; and (3) increase early central venous catheter (CVC) placement. METHODS: Critically ill, medical, nontrauma patients who were transported from September 2007 through February 2009 by University of Massachusetts (UMass) Memorial LifeFlight, a university-based emergency medical helicopter service, were eligible for enrollment. Patients were prospectively randomized to receive a fingerstick whole-blood lactate measurement on an alternate-day schedule. Flight crews were not blinded to results. Flight crews were asked to inform the receiving attending physician of the results. The primary endpoint was the ability of a high, prehospital lactate value [> 4 millimoles per liter (mmol/L)] to identify mortality. Secondary endpoints included differences in post-transport fluid, transfusion, and intubation, and decrease in time to central venous catheter (CVC) placement. Categorical variables were compared between groups by Fisher's Exact Test, and continuous variables were compared by t-test. RESULTS: Patients (N = 59) were well matched for age, gender, and acuity. In the lactate cohort (n = 20), mean lactate was 7 mmol/L [Standard error of the mean, SEM = 1]. Initial analysis revealed that prehospital lactate levels of ≥ 4 mmol/L did show a trend toward higher mortality with an odds ratio of 2.1 (95% CI, 0.3-13.8). Secondary endpoints did not show a statistically significant change in management between the lactate and non lactate groups. There was a trend toward decreased time to post-transport CVC in the non lactate faction. CONCLUSION: Prehospital aeromedical point-of-care lactate measurement levels ≥ 4 mmol/L may help stratify mortality. Further investigation is needed, as this is a small, limited study. The initial analysis did not find a significant change in post-transport management.
Subject(s)
Air Ambulances , Critical Illness , Emergency Medical Services/organization & administration , Lactates/analysis , Point-of-Care Systems , Endpoint Determination , Female , Hospital Mortality , Humans , Male , Massachusetts , Middle Aged , Predictive Value of Tests , Prospective StudiesABSTRACT
BACKGROUND: Efforts to reduce door-to-balloon (DTB) times for patients presenting with an ST-elevation myocardial infarction (STEMI) are widespread. Reductions in DTB times have been shown to reduce short-term mortality and decrease inpatient length of stay (LOS) in these high-risk patients. However, there is a limited literature examining the effect that these quality improvement (QI) initiatives have on patient care costs. METHODS: A STEMI QI program (Cardiac Alert Team [CAT]) initiative was instituted in July 2006 at a single tertiary care medical center located in central Massachusetts. Information was collected on cost data and selected clinical outcomes for consecutively admitted patients with a STEMI. Differences in adjusted hospital costs were compared in three cohorts of patients hospitalized with a STEMI: one before the CAT initiative began (January 2005-June 2006) and two after (October 1, 2007-September 30, 2009, and October 1, 2009-September 30, 2011). RESULTS: Before the CAT initiative, the average direct inpatient costs related to the care of these patients was $14,634, which decreased to $13,308 (-9.1%) and $13,567 (-7.3%) in the two sequential periods of the study after the CAT initiative was well established. Mean DTB times were 91 minutes before the CAT initiative and were reduced to 55 and 61 minutes in the follow-up periods (p < .001). There was a nonsignificant reduction in LOS from 4.4 days pre-CAT to 3.6 days in both of the post-CAT periods (p = .11). CONCLUSIONS: A QI program aimed at reducing DTB times for patients with a STEMI also led to a significant reduction in inpatient care costs. The greatest reduction in costs was related to cardiac catheterization, which was not expected and was likely a result of standardization of care and identification of practice inefficiencies.
Subject(s)
Clinical Protocols , Cost Savings/methods , Myocardial Infarction/economics , Myocardial Infarction/therapy , Quality Improvement/organization & administration , Communication , Electrocardiography , Electronic Health Records/organization & administration , Female , Humans , Male , Massachusetts , Middle Aged , Quality Improvement/economics , Retrospective StudiesABSTRACT
BACKGROUND: Deep learning has been successfully applied to ECG data to aid in the accurate and more rapid diagnosis of acutely decompensated heart failure (ADHF). Previous applications focused primarily on classifying known ECG patterns in well-controlled clinical settings. However, this approach does not fully capitalize on the potential of deep learning, which directly learns important features without relying on a priori knowledge. In addition, deep learning applications to ECG data obtained from wearable devices have not been well studied, especially in the field of ADHF prediction. METHODS: We used ECG and transthoracic bioimpedance data from the SENTINEL-HF study, which enrolled patients (≥21 years) who were hospitalized with a primary diagnosis of heart failure or with ADHF symptoms. To build an ECG-based prediction model of ADHF, we developed a deep cross-modal feature learning pipeline, termed ECGX-Net, that utilizes raw ECG time series and transthoracic bioimpedance data from wearable devices. To extract rich features from ECG time series data, we first adopted a transfer learning approach in which ECG time series were transformed into 2D images, followed by feature extraction using ImageNet-pretrained DenseNet121/VGG19 models. After data filtering, we applied cross-modal feature learning in which a regressor was trained with ECG and transthoracic bioimpedance. Then, we concatenated the DenseNet121/VGG19 features with the regression features and used them to train a support vector machine (SVM) without bioimpedance information. RESULTS: The high-precision classifier using ECGX-Net predicted ADHF with a precision of 94 %, a recall of 79 %, and an F1-score of 0.85. The high-recall classifier with only DenseNet121 had a precision of 80 %, a recall of 98 %, and an F1-score of 0.88. We found that ECGX-Net was effective for high-precision classification, while DenseNet121 was effective for high-recall classification. CONCLUSION: We show the potential for predicting ADHF from single-channel ECG recordings obtained from outpatients, enabling timely warning signs of heart failure. Our cross-modal feature learning pipeline is expected to improve ECG-based heart failure prediction by handling the unique requirements of medical scenarios and resource limitations.
Subject(s)
Heart Failure , Wearable Electronic Devices , Humans , Heart Failure/diagnosis , Electrocardiography , Support Vector MachineABSTRACT
BACKGROUND: Standard of care for patients with acute coronary syndrome/ST-segment elevation myocardial infarction (ACS/STEMI) is rapid revascularization of ischemic myocardium. Current optimal treatment is primary percutaneous coronary intervention (PCI) within 90 minutes after the patient accesses the health care system, and strategies to lower this time may improve outcomes. OBJECTIVE: To compare interhospital transport times (TTs) before and after instituting a no-medication-infusion policy during transport of ACS patients. Our hypothesis was that transporting patients using only bolus medications would significantly reduce transport times without increasing hospital length of stay (LOS) or increasing mortality. METHODS: We conducted an institutional review board (IRB)-approved retrospective chart review of all patients transferred from an outlying hospital to a primary PCI center using either critical care helicopter or ground transport. The study period was January 2006 through January 2008, with the policy of discontinuing infusions instituted in April 2007. The TT was calculated using departure and arrival times from dispatch logs. The LOS was determined via electronic medical record review. The TT and LOS differences were calculated using two-tailed t-tests with Welch's correction where appropriate. Results. A total of 154 ACS/STEMI transports were completed during the study period (74 before and 80 after policy initiation). The mean (+/- standard error of the mean) TT was 43.5 +/- 1.2 minutes before the policy and 37.1 +/- 0.9 minutes after the policy (p < 0.01). To specifically address different transport distances, we analyzed TTs from an identical group of referral hospitals in both the before- and after-policy groups. A significant reduction in TT remained in this after-policy group (TTs 43.5 +/- 1.2 minutes before the policy and 37.1 +/- 0.9 minutes after; p = 0.01). Data on LOS were available for 127 patients (58 patients before and 69 patients after) and averaged 4.6 +/- 0.8 days prior to the new policy and 3.9 +/- 0.4 days after (p = 0.41). Overall, only one patient died (after-policy group) (p = not significant). CONCLUSIONS: A policy of transferring patients from one hospital directly to a cardiac catheterization laboratory using only bolus medications significantly reduces total door-to-needle time without adverse effects on LOS or mortality. Other institutions may want to consider such policies for interfacility transport of ACS patients.
Subject(s)
Acute Coronary Syndrome , Infusions, Intravenous , Transportation of Patients/methods , Adult , Aged , Aged, 80 and over , Air Ambulances , Female , Humans , Male , Medical Audit , Middle Aged , Organizational Policy , Retrospective Studies , Time FactorsABSTRACT
OBJECTIVE: To examine the ability of the family-rated Family Confusion Assessment Method (FAM-CAM) to identify delirium in the emergency department (ED) among patients with and without dementia, as compared to the reference-standard Confusion Assessment Method (CAM). DESIGN: Validation study. SETTING: Urban academic ED. PARTICIPANTS: Dyads of ED patients, aged 70 years and older, and their family caregivers (N = 108 dyads). MEASUREMENTS: A trained reference standard interviewer performed a cognitive screen, delirium symptom assessment, and scored the CAM. The caregiver self-administered the FAM-CAM. Dementia was assessed using the Informant Questionnaire on Cognitive Decline in the Elderly and the medical record. For concurrent validity, performance of the FAM-CAM was compared to the CAM. For predictive validity, clinical outcomes (ED visits, hospitalization, and mortality) over 6 months were compared in FAM-CAM positive and negative patients, controlling for age, sex, comorbidity, and cognitive status. RESULTS: Among the 108 patients, 30 (28%) were CAM positive for delirium and 58 (54%) presented with dementia. The FAM-CAM had a specificity of 83% and a negative predictive value of 83%. Most false negatives (n = 9 of 13, 69%) were due to caregivers not identifying the inattention criteria for delirium on the FAM-CAM. In patients with dementia, sensitivity was higher than in patients without (61% vs 43%). In adjusted models, a hospitalization in the following 6 months was more than three times as likely in FAM-CAM positive compared to negative patients (odds ratio = 3.4; 95% confidence interval = 1.2-9.3). CONCLUSIONS: Among patients with and without dementia, the FAM-CAM shows qualities that are important in the ED setting for identification of delirium. Using the FAM-CAM as part of a systematic screening strategy for the ED, in which families' assessments could supplement healthcare professionals' assessments, is promising. J Am Geriatr Soc 68:983-990, 2020.
Subject(s)
Caregivers , Delirium/diagnosis , Mental Status and Dementia Tests/standards , Aged , Aged, 80 and over , Case-Control Studies , Comorbidity , Delirium/epidemiology , Dementia/epidemiology , Emergency Service, Hospital/organization & administration , Emergency Service, Hospital/statistics & numerical data , Family , Female , Humans , Male , Predictive Value of Tests , Prospective Studies , Single-Blind MethodABSTRACT
OBJECTIVE: The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful.
Subject(s)
Anticoagulants/therapeutic use , House Calls/trends , Patient Transfer/methods , Pharmacists/standards , Quality of Health Care/standards , Referral and Consultation/standards , Venous Thromboembolism/therapy , Aged , Female , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Accumulation of excess body fluid and autonomic dysregulation are clinically important characteristics of acute decompensated heart failure. We hypothesized that transthoracic bioimpedance, a noninvasive, simple method for measuring fluid retention in lungs, and heart rate variability, an assessment of autonomic function, can be used for detection of fluid accumulation in patients with acute decompensated heart failure. OBJECTIVE: We aimed to evaluate the performance of transthoracic bioimpedance and heart rate variability parameters obtained using a fluid accumulation vest with carbon black-polydimethylsiloxane dry electrodes in a prospective clinical study (System for Heart Failure Identification Using an External Lung Fluid Device; SHIELD). METHODS: We computed 15 parameters: 8 were calculated from the model to fit Cole-Cole plots from transthoracic bioimpedance measurements (extracellular, intracellular, intracellular-extracellular difference, and intracellular-extracellular parallel circuit resistances as well as fitting error, resonance frequency, tissue heterogeneity, and cellular membrane capacitance), and 7 were based on linear (mean heart rate, low-frequency components of heart rate variability, high-frequency components of heart rate variability, normalized low-frequency components of heart rate variability, normalized high-frequency components of heart rate variability) and nonlinear (principal dynamic mode index of sympathetic function, and principal dynamic mode index of parasympathetic function) analysis of heart rate variability. We compared the values of these parameters between 3 participant data sets: control (n=32, patients who did not have heart failure), baseline (n=23, patients with acute decompensated heart failure taken at the time of admittance to the hospital), and discharge (n=17, patients with acute decompensated heart failure taken at the time of discharge from hospital). We used several machine learning approaches to classify participants with fluid accumulation (baseline) and without fluid accumulation (control and discharge), termed with fluid and without fluid groups, respectively. RESULTS: Among the 15 parameters, 3 transthoracic bioimpedance (extracellular resistance, R0; difference in extracellular-intracellular resistance, R0 - R∞, and tissue heterogeneity, α) and 3 heart rate variability (high-frequency, normalized low-frequency, and normalized high-frequency components) parameters were found to be the most discriminatory between groups (patients with and patients without heart failure). R0 and R0 - R∞ had significantly lower values for patients with heart failure than for those without heart failure (R0: P=.006; R0 - R∞: P=.001), indicating that a higher volume of fluids accumulated in the lungs of patients with heart failure. A cubic support vector machine model using the 5 parameters achieved an accuracy of 92% for with fluid and without fluid group classification. The transthoracic bioimpedance parameters were related to intra- and extracellular fluid, whereas the heart rate variability parameters were mostly related to sympathetic activation. CONCLUSIONS: This is useful, for instance, for an in-home diagnostic wearable to detect fluid accumulation. Results suggest that fluid accumulation, and subsequently acute decompensated heart failure detection, could be performed using transthoracic bioimpedance and heart rate variability measurements acquired with a wearable vest.
ABSTRACT
Mechanical circulatory support is increasingly used as a long-term treatment option for patients with end-stage heart failure. Patients with implanted ventricular assist devices are at high risk for a range of diverse medical urgencies and emergencies. Given the increasing prevalence of mechanical circulatory support devices, this expert clinical consensus document seeks to help inform emergency medicine and prehospital providers regarding the approach to acute medical and surgical conditions encountered in these complex patients.
Subject(s)
Emergency Medicine/education , Heart Failure/therapy , Heart-Assist Devices/adverse effects , Consensus , Emergency Medicine/standards , HumansABSTRACT
Preventing utilization of hospital and emergency department after diagnosis of venous thromboembolism is a complex problem. The objective of this study is to assess the impact of a care transition intervention on hospitalizations and emergency department visits after venous thromboembolism. We randomized adults diagnosed with a new episode of venous thromboembolism to usual care or a multicomponent intervention that included a home pharmacist visit in the week after randomization (typically occurring at time of discharge), illustrated medication instructions distributed during home visit, and a follow-up phone call with an anticoagulation expert scheduled for 8 to 30 days from time of randomization. Through physician chart review of the 90 days following randomization, we measured the incidence rate of hospital and emergency department visits for each group and their ratio. We also determined which visits were related to recurrent venous thromboembolism, bleeding, or anticoagulation and which where preventable. We enrolled 77 intervention and 85 control patients. The incidence rate was 4.50 versus 6.01 visits per 1000 patient days in the intervention versus control group (incidence rate ratio = 0.71; 95% confidence interval = 0.40-1.27). Most visits in the control group were not related to venous thromboembolism or bleeding (21%) and of those that were, most were not preventable (25%). The adjusted incidence rate ratio for the intervention was 1.05 (95% confidence interval = 0.57-1.91). Our patients had a significant number of hospital and emergency department visits after diagnosis. Most visits were not related to recurrent venous thromboembolism or bleeding and of those that were, most were not preventable. Our multicomponent intervention did not decrease hospitalizations and emergency department visits.
Subject(s)
Continuity of Patient Care , Emergency Service, Hospital/statistics & numerical data , Hospitalization/statistics & numerical data , Patient Education as Topic , Venous Thromboembolism/therapy , Adult , Anticoagulants/therapeutic use , Female , Home Care Services , Humans , Male , Patient Discharge , PharmacistsABSTRACT
Risk stratifying patients with potential acute coronary syndromes (ACS) in the Emergency Department is an imprecise and resource-consuming process. ACS cannot be ruled in or out efficiently in a majority of patients after initial history, physical exam, and ECG are analyzed. This has led to a reliance on cardiac markers of myocardial necrosis as a key means of making the diagnosis. Commonly used markers, CK-MB and troponin-I, have the drawback of delayed sensitivity. This has led to an ongoing search for one or more marker(s) that would be more sensitive in early ACS. With the central role that platelets play in the pathophysiology of coronary thrombosis, measures of platelet function represent one potential area where an early ACS marker might be identified. This review will focus on selected tests/markers of platelet function that have shown some promise with respect to the risk stratification of patients with potential ACS.
Subject(s)
Acute Coronary Syndrome/blood , Acute Coronary Syndrome/diagnosis , Emergency Medical Services/methods , Platelet Activation , Acute Coronary Syndrome/physiopathology , Biomarkers/blood , Humans , Platelet Function Tests/methods , Sensitivity and Specificity , Time FactorsABSTRACT
BACKGROUND: Depression and anxiety are common and associated with worse clinical outcomes in patients who experience an acute coronary syndrome (ACS). We investigated the association between major ventricular arrhythmias (VAs) with the progression of depression and anxiety among hospital survivors of an ACS. METHODS: Patients were interviewed in hospital and by telephone up to 12â¯months after hospital discharge. The primary outcome was the presence of moderate/severe symptoms of depression and anxiety defined as a Patient Health Questionnaire (PHQ)-9 scoreâ¯≥â¯10 and a Generalized Anxiety Disorder (GAD)-7 scoreâ¯≥â¯10 at baseline and 1â¯month and PHQ-2â¯≥â¯3 and GAD-2â¯≥â¯3 at 3, 6, and 12â¯months. We used marginal models to examine the association between major VAs and the symptoms of depression or anxiety over time. RESULTS: The average age of the study population (nâ¯=â¯2074) was 61.1â¯years, 33.5% were women, and 78.3% were white. VAs developed in 105 patients (5.1%). Symptoms of depression and anxiety were present in 22.2% and 23.5% of patients at baseline, respectively, and declined to 14.1% and 12.6%, respectively, at 1-month post-discharge. VAs were not significantly associated with the progression of symptoms of depression (adjusted relative risk [aRR]â¯=â¯1.29, 95% confidence interval [CI]â¯=â¯0.94-1.77) and anxiety (aRRâ¯=â¯1.22, 95% CIâ¯=â¯0.86-1.72), or with change in average scores of PHQ-2 and GAD-2 over time, both before and after risk adjustment. CONCLUSION: The prevalence of symptoms of depression and anxiety was high after an ACS but declined thereafter and may not be associated with the occurrence of major in-hospital VAs.